These researchers would be in Africa fighting ebola—but Trump cut their funding
US Infectious diseases centers launched during COVID have lost their funding under Trump.
As the world struggles to contain the rapidly growing Ebola outbreak in the Democratic Republic of the Congo’s Ituri Province, a vital network of research centers has been unable to help on the ground. The reason: The Trump administration slashed its funding last year, in part due to conspiracy theories about the origins of COVID-19.
Established in 2020 by the National Institutes of Health, the Centers for Research in Emerging Infectious Diseases (CREID) Network was conducting research into viruses that emerge from wildlife and spill over to people, including the family of viruses that Ebola belongs to. The network operated 10 sites around the world where these types of disease outbreaks are likely to occur, including in Central and East Africa. (The network was also researching hantavirus, a disease that saw a recent rare outbreak on a cruise ship.)
NIH provided CREID with approximately $82 million in funding over five years, and its funding was up for renewal in 2025. But last June, the centers received a stop-work order stating that their research had been deemed “unsafe for Americans and not a good use of taxpayer funding,” and that the agency’s priorities no longer supported the network.
This story was first published by Ars Technica. Read the original report